| 000 | 01776 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515033146.0 | ||
| 264 | 0 | _c20060821 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0275-004X | ||
| 024 | 7 |
_a10.1097/01.iae.0000224942.59481.c9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRuiz-Moreno, José Maria | |
| 245 | 0 | 0 |
_aPhotodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome. _h[electronic resource] |
| 260 |
_bRetina (Philadelphia, Pa.) _c |
||
| 300 |
_a602-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aChoroidal Neovascularization _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aExudates and Transudates |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections |
| 650 | 0 | 4 |
_aMacular Degeneration _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhotochemotherapy |
| 650 | 0 | 4 |
_aPhotosensitizing Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aPorphyrins _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetreatment |
| 650 | 0 | 4 |
_aTriamcinolone Acetonide _xadministration & dosage |
| 650 | 0 | 4 | _aVerteporfin |
| 650 | 0 | 4 | _aVisual Acuity |
| 650 | 0 | 4 |
_aVitreous Body _xdrug effects |
| 700 | 1 | _aMontero, Javier A | |
| 700 | 1 | _aBarile, Stefano | |
| 700 | 1 | _aZarbin, Marco A | |
| 773 | 0 |
_tRetina (Philadelphia, Pa.) _gvol. 26 _gno. 6 _gp. 602-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.iae.0000224942.59481.c9 _zAvailable from publisher's website |
| 999 |
_c16421323 _d16421323 |
||